Education
About Us
Working with TipRanks
Follow Us
Vivos Therapeutics (VVOS)
NASDAQ:VVOS
Vivos Therapeutics (VVOS) Ownership Overview
1.13% Mutual Funds
3.17% Other Institutional Investors
3.11% ETFs
92.59% Public Companies and
Individual Investors
The ownership structure of Vivos Therapeutics (VVOS) stock is a mix of institutional, retail, and individual investors. Approximately 7.41% of the company’s stock is owned by Institutional Investors, and 92.59% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 273,329 | Institution | 3.04% | 541,191 | |
| 73,061 | Insider | 0.97% | 180,461 | |
| 60,629 | Institution | 0.67% | 120,045 | |
| 52,834 | Institution | 0.59% | 104,611 | |
| 6,102 | Institution | 0.07% | 12,082 | |
| 80 | Insider | <0.01% | 198 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 60,629 | Institution | 0.67% | 120,045 | |
| 52,834 | Institution | 0.59% | 104,611 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 212,700 | Institution | 2.37% | 480,702 | |
| 60,629 | Institution | 0.67% | 137,022 | |
| 4,871 | Institution | 0.05% | 9,498 | |
| 1,231 | Institution | 0.01% | 2,400 |
FAQ
Who Owns Vivos Therapeutics (VVOS)?
Currently, no data Available
What percentage of Vivos Therapeutics (VVOS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.17% of Vivos Therapeutics (VVOS) stock is held by institutional investors.
What percentage of Vivos Therapeutics (VVOS) stock is held by retail investors?
According to the latest TipRanks data, approximately 92.59% of Vivos Therapeutics (VVOS) stock is held by retail investors.
Who owns the most shares of Vivos Therapeutics (VVOS)?
Vanguard owns the most shares of Vivos Therapeutics (VVOS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.